Previous Close | 42.98 |
1-Year Change | -9.44% |
6-Months Change | 20.66% |
3-Months Change | 1.8% |
Moving Avg (50d) | 42.628 |
Moving Avg (200d) | 39.489 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 4.46B |
Beta (3-Years) | 1.05 |
Revenue Growth (ttm) | 0.01% |
Net Profit Margin (ttm) | 1.31% |
Return On Assets (ttm) | 0.88% |
EPS (ttm) | 0.69 |
PE Ratio (ttm) | 62.29 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Life Sciences Tools & Services |
Country: | United States |
Syneos Health is an American provider of contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina, the company specializes in helping other companies with late-stage clinical trials, but also provides commercial services to market health treatments. Syneos Health was formed from the merger of InVentiv Health and INC Research, each... Wikipedia